A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(170 sites)

United States

Local Institution - 0120, Glendale, Arizona

Pillar Clinical Research - Richardson, Bentonville, Arkansas

Pillar Clinical Research- Little Rock, Little Rock, Arkansas

Woodland International Research Group, Little Rock, Arkansas

Woodland Research Northwest, Rogers, Arkansas